COVID‐19 pandemic and allergen immunotherapy—an EAACI survey

BACKGROUND: As in many fields of medical care, the coronavirus disease 2019 (COVID‐19) resulted in an increased uncertainty regarding the safety of allergen immunotherapy (AIT). Therefore, the European Academy of Allergy and Clinical Immunology (EAACI) aimed to analyze the situation in different cou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy
Main Authors: Pfaar, Oliver, Agache, Ioana, Bonini, Matteo, Brough, Helen Annaruth, Chivato, Tomás, Del Giacco, Stefano R., Gawlik, Radoslaw, Gelincik, Aslı, Hoffmann‐Sommergruber, Karin, Jutel, Marek, Klimek, Ludger, Knol, Edward F., Lauerma, Antti, Ollert, Markus, O’Mahony, Liam, Mortz, Charlotte G., Palomares, Oscar, Riggioni, Carmen, Schwarze, Jürgen, Skypala, Isabel, Torres, María José, Untersmayr, Eva, Walusiak‐Skorupa, Jolanta, Chaker, Adam, Giovannini, Mattia, Heffler, Enrico, Jensen‐Jarolim, Erika, Quecchia, Cristina, Sandoval‐Ruballos, Mónica, Sahiner, Umit, Tomić Spirić, Vesna, Alvaro‐Lozano, Montserrat
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
ORIGINAL ARTICLES
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013670/
https://ncbi.nlm.nih.gov/pubmed/33655519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14793
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados